Cyclin D1 anticorps (AA 158-184)
Aperçu rapide pour Cyclin D1 anticorps (AA 158-184) (ABIN2738930)
Antigène
Voir toutes Cyclin D1 (CCND1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 158-184
-
Purification
- Immunogen affinity purified
-
Immunogène
- A synthetic peptide corresponding to a sequence in the middle region of human CCND1(158-184aa HDFIEHFLSKMPEAEENKQIIRKHAQT), different from the related mouse sequence by two amino acids, and from the related rat sequence by one amino acid.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg sodium phosphate, 0.05 mg sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- avoid freeze thaw cycles
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- Cyclin D1 (CCND1)
-
Autre désignation
- CCND1 / Cyclin D1
-
Sujet
-
Name/Gene ID: CCND1
Synonyms: CCND1, B-cell lymphoma 1 protein, BCL-1 oncogene, B-cell CLL/lymphoma 1, BCL-1, Cyclin D1, G1/S-specific cyclin-D1, U21B31, PRAD1, BCL1, D11S287E, PRAD1 oncogene -
ID gène
- 595
-
Pathways
- Signalisation PI3K-Akt, Cycle Cellulaire, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
Antigène
-